» Articles » PMID: 222469

Cellular Regulation of Mammalian Sarcoma Virus Expression: a Gene Regulation Model for Oncogenesis

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1979 Apr 1
PMID 222469
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Investigations aimed at defining cellular functions required for expression of transformation by mammalian sarcoma viruses have led to the isolation of a class of revertants that contain biologically active feline sarcoma virus, yet possess in vitro and in vivo properties of normal cells. The block to expression of the transformed state in these cellular revertants was spontaneously reversible at low frequency. Moreover, infection with certain helper viruses reversed the block at very high efficiency. Helper virus complementation was shown not to be a direct effect of helper virus functions expressed in the initially infected revertant cell. Rather, the helper virus acted indirectly by rescuing sarcoma virus and allowing it to infect and transform another cell within the revertant population. Using biochemical and immunologic techniques, it was possible to demonstrate a specific and very marked reduction in transcriptional and translational products of the sarcoma viral genome in the revertant cells. Findings that the reversal of this block was associated with reacquisition of the transformed phenotype, together with other evidence, suggest that reversion results from cellular transcriptional regulation of the integrated sarcoma virus genome. Reversion in this virus transformation system provides a model for oncogenesis resulting from derepression of cellular genes that possess malignant potential.

Citing Articles

Frequent hereditable shutdown of murine retrovirus gene expression in murine cell lines.

Bestwick R, Machida C, Polonoff E, Kabat D Mol Cell Biol. 1984; 4(5):908-14.

PMID: 6727872 PMC: 368838. DOI: 10.1128/mcb.4.5.908-914.1984.


Expression of Kirsten murine sarcoma virus in transformed nonproducer and revertant NIH/3T3 cells: evidence for cell-mediated resistance to a viral oncogene in phenotypic reversion.

Norton J, Cook F, Roberts P, Clewley J, Avery R J Virol. 1984; 50(2):439-44.

PMID: 6323744 PMC: 255641. DOI: 10.1128/JVI.50.2.439-444.1984.


Revertants and partial transformants of rat fibroblasts infected with Fujinami sarcoma virus.

Mathey-Prevot B, Shibuya M, Samarut J, Hanafusa H J Virol. 1984; 50(2):325-34.

PMID: 6323733 PMC: 255624. DOI: 10.1128/JVI.50.2.325-334.1984.


Involvement of a high-molecular-weight polyprotein translational product of Snyder-Theilen Feline sarcoma virus in malignant transformation.

Reynolds Jr F, Van de Ven W, Blomberg J, Stephenson J J Virol. 1981; 37(2):643-53.

PMID: 6261011 PMC: 171052. DOI: 10.1128/JVI.37.2.643-653.1981.


Cellular transformation by subgenomic feline sarcoma virus DNA.

Barbacid M J Virol. 1981; 37(1):518-23.

PMID: 6261000 PMC: 171032. DOI: 10.1128/JVI.37.1.518-523.1981.